ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MDCN Medican Enterprises Inc (PK)

0.000001
0.00 (0.00%)
25 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Medican Enterprises Inc (PK) USOTC:MDCN OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.000001 0.0001 0.0001 0.000001 0.0001 18,840,000 14:48:38

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

14/08/2015 7:18pm

Edgar (US Regulatory)




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 12b-25
NOTIFICATION OF LATE FILING

SEC FILE NUMBER:
000-53408
CUSIP NUMBER:
56464T


(Check One):
o
Form 10-K
o
Form 20-F
o
Form 11-K
x
Form 10-Q
o
Form N-SAR
o
Form N-CSR
 
For Period Ended:     June 31, 2015   

 
o
Transition Report on Form 10-K
 
o
Transition Report on Form 20-F
 
o
Transition Report on Form 11-K
 
o
Transition Report on Form 10-Q
 
o
Transition Report on Form N-SAR

Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I --  REGISTRANT INFORMATION
 
Medican Enterprises, Inc.

Full Name of Registrant
 

Former Name if Applicable
 
3440 E. Russell Road

Address of Principal Executive Office (Street and Number)
 
Las Vegas, NV 89120

City, State and Zip Code
 

 
 

 

 
PART II --  RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.  (Check box if appropriate)

x
(a)
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

x
(b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

o
(c)
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
 
The Registrant did not obtain all the necessary information prior to the filing date, the attorneys and accountants could not complete the required legal information and financial statements, and management could not complete the Management's Discussion and Analysis of such financial statements prior to the filing deadline.

 SEC 1344 (04-09)
Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

PART IV-- OTHER INFORMATION
 
(1)
 
Name and telephone number of person to contact in regard to this notification
 
 
Kenneth Williams
 
(800)
 
416-8802
 
 
(Name)
 
(Area Code)
 
(Telephone Number)
 
 
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

   
Yes
x
 
No
o

(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

   
Yes
o
 
No
x
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Medican Enterprises, Inc.
 
 
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 14, 2015
By: /s/ Kenneth Williams
 
 
Kenneth Williams, Chief Executive Officer and Director
 
    

 
 

 

1 Year Medican Enterprises (PK) Chart

1 Year Medican Enterprises (PK) Chart

1 Month Medican Enterprises (PK) Chart

1 Month Medican Enterprises (PK) Chart

Your Recent History

Delayed Upgrade Clock